The Zacks Consumer Staples sector has held up relatively well in 2022, down roughly 9% and easily outperforming the S&P 500.
Companies in the realm possess the ability to generate revenue in the face of many economic backdrops, helping explain why the sector has held up better than most.
A big-time player in the realm, Colgate-Palmolive CL, is on deck to unveil quarterly earnings on October 28th before the market open.
Colgate-Palmolive distributes and produces a wide array of consumer products, including household, health care, and personal care products.
Currently, CL carries a Zacks Rank #4 (Sell) paired with an overall VGM Score of a D.
Let’s take a deeper dive into how the company shapes up heading into its print.
Share Performance & Valuation
Colgate-Palmolive shares have held up better than the general market YTD, down 12% vs. the S&P 500’s roughly 20% decline.
Image Source: Zacks Investment Research
Over the last three months, however, CL shares have marginally underperformed the S&P 500, down nearly 7%.
Image Source: Zacks Investment Research
Further, CL shares trade at a 24.4X forward earnings multiple, a tick above its five-year median and reflecting a 25% premium relative to the Zacks Consumer Staples sector average of 19.6X.
The company carries a Value Style Score of a D.
Image Source: Zacks Investment Research
Quarterly Estimates
Analysts have primarily been bearish in their earnings outlook, with four negative earnings estimate revisions coming in over the last several months. The Zacks Consensus EPS Estimate of $0.74 indicates a Y/Y decline in earnings of roughly 8.5%.
Image Source: Zacks Investment Research
Colgate-Palmolive’s top-line is in better standing; the Zacks Consensus Sales Estimate of $4.5 billion suggests Y/Y revenue growth of 2%.
Quarterly Performance & Market Reactions
Colgate-Palmolive has primarily reported earnings in-line with the Zacks Consensus EPS Estimate, posting breakeven surprises in five of its last ten reports. However, CL registered a slight 1.4% EPS beat in its latest print.
Top-line results have consistently come in above expectations; CL has exceeded the Zacks Consensus Sales Estimate in eight of its last ten quarters. Below is a chart illustrating the company’s revenue on a quarterly basis.
Image Source: Zacks Investment Research
In addition, it’s worth noting that CL shares have moved downward following five of its last six quarterly prints.
Putting Everything Together
CL shares have outperformed the market YTD but have slightly lagged over the last three months, indicating that the buying has slowed.
The company’s forward earnings multiple sits above its five-year median and Zacks Consumer Staples sector average.
Analysts have been bearish in their earnings outlook, and estimates suggest a Y/Y decline in earnings but an uptick in revenue, likely reflecting rising costs eating into margins.
The company has primarily reported earnings in line with the Zacks Consensus EPS Estimate, and the market hasn’t reacted well following the majority of its last six prints.
Heading into the release, Colgate-Palmolive CL carries a Zacks Rank #4 (Sell) paired with an Earnings ESP Score of -0.3%.
This Little-Known Semiconductor Stock Could Be Your Portfolio’s Hedge Against Inflation
Everyone uses semiconductors. But only a small number of people know what they are and what they do. If you use a smartphone, computer, microwave, digital camera or refrigerator (and that’s just the tip of the iceberg), you have a need for semiconductors. That’s why their importance can’t be overstated and their disruption in the supply chain has such a global effect. But every cloud has a silver lining. Shockwaves to the international supply chain from the global pandemic have unearthed a tremendous opportunity for investors. And today, Zacks’ leading stock strategist is revealing the one semiconductor stock that stands to gain the most in a new FREE report. It’s yours at no cost and with no obligation.>>Yes, I Want to Help Protect My Portfolio During the Recession
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
ColgatePalmolive Company (CL): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Image and article originally from www.nasdaq.com. Read the original article here.